About Carlyle AlpInvest

• Founded: 2000 (acquired by Carlyle Group in 2011)

• Headquarters: Amsterdam, Netherlands

• AUM: $85bn (as of 2023)

• Strategy: Secondaries, co-investments, and primaries across private equity, infrastructure, private debt, and real estate

• Track record: One of the largest secondaries investors globally, with over 450 fund investments and 900 co-investments since inception

• Leadership: Wim Borgdorff (Global Head), Greg Belinfanti (Co-Head of Secondaries)

Carlyle AlpInvest closed Atom Fund II at its $1.7bn hard cap, 70% above the initial $1bn target. The vehicle focuses exclusively on single-asset continuation fund deals, where a GP rolls a portfolio company out of an aging fund into a new structure. The oversubscription follows Atom Fund I's $1.1bn close in 2021. LPs included pension funds and insurance companies, though specific allocations were not disclosed.

The 70% oversubscription signals continued LP appetite for continuation vehicle strategies despite broader secondaries market repricing. Single-asset deals accounted for roughly 45% of GP-led secondaries volume in 2023, up from 30% three years earlier, according to Evercore. Carlyle AlpInvest's rapid follow-on at a larger size suggests LPs view continuation vehicle investing as a distinct sleeve within secondaries allocation — one that offers more control over asset selection than traditional LP stake purchases. The firm's ability to source deals through Carlyle's broader platform likely helped differentiate the fund in a competitive GP-led market.

The test for Atom II will be deployment pace relative to fund size. Single-asset continuation deals have grown larger — median transaction size exceeded $500m in 2023 — but the market remains deal-by-deal, with no guarantee of consistent flow. Carlyle AlpInvest deployed Atom I over roughly 24 months, a pace that would require sourcing 8–10 deals for Atom II given the step-up in capital. If the market for large single-asset continuations tightens or pricing expectations diverge between GPs and secondaries buyers, the fund could face extended deployment timelines or pressure to participate in smaller deals that don't move the needle on a $1.7bn pool.

Source: AltAssets